
MetaVia Inc.
MTVAHealthcare|Biotechnology|US
$1.43
+0.34 (+31.19%)
DCF Value
$5.15
Tangible Book / Share
$1.15
Cash / Share
$2.13
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Apr 7, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
MetaVia Announces Statistically Significant 68% Reduction in Liver Fat from DA-1726 Phase 1 Part 3B Interim Data
Nov 5, 2026 · PRNewsWire
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026
Oct 28, 2026 · PRNewsWire
SEC Filings (77)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 28, 2026 | 8-K | Material event | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 15, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 10, 2026 | 8-K | Material event | DocumentIndex |
| Apr 7, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 6, 2026 | EFFECT | DocumentIndex | |
| Apr 3, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Apr 3, 2026 | POS AM | DocumentIndex | |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Mar 18, 2026 | 8-K | Material event | DocumentIndex |
| Jan 27, 2026 | 8-K | Material event | DocumentIndex |
| Jan 16, 2026 | 8-K | Material event | DocumentIndex |
| Jan 16, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Jan 15, 2026 | EFFECT | DocumentIndex | |
| Jan 15, 2026 | S-1MEF | IPO / offering registration | DocumentIndex |
| Jan 12, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Jan 6, 2026 | FWP | DocumentIndex | |
| Jan 5, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jan 5, 2026 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |
| Dec 2, 2025 | 8-K | Material event | DocumentIndex |
| Nov 26, 2025 | 8-K | Material event | DocumentIndex |
| Nov 7, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Oct 17, 2025 | DRS | DocumentIndex | |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |